A detailed history of Marotta Asset Management transactions in Astrazeneca PLC stock. As of the latest transaction made, Marotta Asset Management holds 12,998 shares of AZN stock, worth $873,465. This represents 0.2% of its overall portfolio holdings.

Number of Shares
12,998
Previous 13,185 1.42%
Holding current value
$873,465
Previous $1.03 Million 1.56%
% of portfolio
0.2%
Previous 0.21%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 03, 2024

SELL
$76.67 - $87.62 $14,337 - $16,384
-187 Reduced 1.42%
12,998 $1.01 Million
Q2 2024

Jul 17, 2024

BUY
$66.81 - $80.83 $25,120 - $30,392
376 Added 2.94%
13,185 $1.03 Million
Q1 2024

Apr 02, 2024

SELL
$61.03 - $69.57 $5,980 - $6,817
-98 Reduced 0.76%
12,809 $867,000
Q4 2023

Jan 03, 2024

SELL
$61.89 - $69.28 $15,410 - $17,250
-249 Reduced 1.89%
12,907 $869,000
Q3 2023

Oct 11, 2023

SELL
$64.85 - $71.7 $15,434 - $17,064
-238 Reduced 1.78%
13,156 $890,000
Q2 2023

Jul 05, 2023

SELL
$69.91 - $75.81 $7,899 - $8,566
-113 Reduced 0.84%
13,394 $958,000
Q4 2022

Jan 03, 2023

SELL
$54.21 - $70.44 $7,968 - $10,354
-147 Reduced 1.08%
13,507 $0
Q3 2022

Oct 11, 2022

SELL
$53.02 - $135.75 $3,499 - $8,959
-66 Reduced 0.48%
13,654 $748,000
Q2 2022

Jul 21, 2022

SELL
$59.26 - $71.14 $24,948 - $29,949
-421 Reduced 2.98%
13,720 $906,000
Q1 2022

Apr 08, 2022

BUY
$55.72 - $67.12 $13,317 - $16,041
239 Added 1.72%
14,141 $938,000
Q4 2021

Jan 13, 2022

BUY
$54.02 - $63.83 $22,418 - $26,489
415 Added 3.08%
13,902 $809,000
Q3 2021

Oct 21, 2021

BUY
$55.56 - $60.79 $1,500 - $1,641
27 Added 0.2%
13,487 $810,000
Q2 2021

Jul 09, 2021

BUY
$48.42 - $60.18 $92,675 - $115,184
1,914 Added 16.58%
13,460 $806,000
Q1 2021

Apr 09, 2021

BUY
$47.16 - $54.44 $544,509 - $628,564
11,546 New
11,546 $574,000

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $208B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Marotta Asset Management Portfolio

Follow Marotta Asset Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Marotta Asset Management, based on Form 13F filings with the SEC.

News

Stay updated on Marotta Asset Management with notifications on news.